During the past decade, Regents of the University of Minnesota conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regents of the University of Minnesota" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Gamida Cell ltd" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regents of the University of Minnesota" #1 collaborator was "Biocompatibles UK Ltd" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Regents of the University of Minnesota" are "Adult Solid Tumor" (1 trials), "Biliary Tract Cancer" (1 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials) and "Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Regents of the University of Minnesota" in a lesser frequency.

Most popular intervention types in "Regents of the University of Minnesota" are "Drug" (8 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cisplatin" (1 trials), "Entrectinib" (1 trials), "Etrolizumab" (1 trials) and "GDA-201" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regents of the University of Minnesota" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Regents of the University of Minnesota". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Regents of the University of Minnesota, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Regents of the University of Minnesota, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".